Related Experiment Video
Updated: Aug 19, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Immunity against the opportunistic fungal pathogen Pneumocystis
Chad Steele1, Judd E Shellito, Jay K Kolls
1Department of Pediatrics, Division of Pulmonology Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA. chad.steele@chp.edu
Abstract:
Species of the genus Pneumocystis exist as opportunistic fungal pathogens and are associated with severe pneumonia and pulmonary complications in immunocompromised individuals. Although prophylactic therapy for Pneumocystis has significantly decreased the overall incidence of infection, more than 80% of cases in current patient populations are considered breakthrough cases. In the HIV-infected population, in the years following the initiation of highly active antiretroviral therapy (HAART), significant reductions in the incidence of Pneumocystis infection were observed, although trends over the last several years suggest that the incidence of Pneumocystis has plateaued rather than decreased. Furthermore, with the more prominent usage of immunosuppressive therapies, the frequency of Pneumocystis infection in the HIV-negative population, such as those with hematologic malignancies and those who have undergone transplantation, has risen significantly. Investigating host defense mechanisms against P. carinii has historically been problematic due to the difficulty in achieving continuous in vitro propagation of proliferating Pneumocytis organisms. Nevertheless, clinical and experimental studies have documented that host defense against Pneumocystis involves a concerted effort between innate, cell-mediated (T lymphocyte) and humoral (B lymphocyte) responses. However, the pulmonary environment is a tissue site where heightened inflammatory responses can often lead to inflammation-mediated injury, thereby contributing to the pathogenesis of Pneumocystis infection. Accordingly, clearance of Pneumocystis from the pulmonary environment is dependent on a delicate equilibrium between the inflammatory response and immune-mediated clearance of the organism. Furthermore, innate and adaptive responses against Pneumocystis are strikingly similar to those against other medically-important fungi, thus providing additional evidence that Pneumocystis exists as a fungal organism.
Insights
Pneumocystis pneumonia remains a threat, especially breakthrough infections in immunocompromised patients. Host defense involves complex immune responses, highlighting the need for further research into fungal pathogen clearance.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Pneumocystis is an opportunistic fungal pathogen causing severe pneumonia in immunocompromised individuals.
- Despite prophylaxis, breakthrough Pneumocystis infections are common, particularly in HIV patients and the immunocompromised.
- Rising incidence in HIV-negative populations (transplant, hematologic malignancy patients) necessitates understanding host defense.
Purpose of the Study:
- To investigate host defense mechanisms against Pneumocystis.
- To understand the role of innate, cell-mediated, and humoral immunity in Pneumocystis infection.
- To explore the balance between inflammation and immune clearance in the pulmonary environment.
Main Methods:
- Review of clinical and experimental studies on host defense against Pneumocystis.
- Analysis of immune responses (innate, T lymphocyte, B lymphocyte) in Pneumocystis infection.
- Examination of the pulmonary inflammatory environment and its role in pathogenesis.
Main Results:
- Host defense against Pneumocystis involves a coordinated effort of innate, T lymphocyte, and B lymphocyte responses.
- The pulmonary environment's inflammatory response can contribute to Pneumocystis pathogenesis.
- Clearance of Pneumocystis depends on balancing inflammation and immune-mediated clearance.
Conclusions:
- Pneumocystis exhibits fungal characteristics, with immune responses similar to other fungal pathogens.
- Understanding the immune equilibrium is crucial for managing Pneumocystis pneumonia.
- Further research is needed to address breakthrough infections and optimize treatment strategies.
Related Concept Videos
Cryptococcal Meningitis
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Atypical Pneumonia
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antifungal Agents
